IRD — Opus Genetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Opus Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24.8	42.7	50.5	30.3	45.1
Net Total Accounts Receivable
Net Total Receivables	—	4.85	2.33	5.77	3.17
Prepaid Expenses
Total Other Current Assets
Total Current Assets	26.1	49	53.9	36.6	50
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.01	0.006	0	0.252	0.199
Total Assets	26.1	49	53.9	36.9	50.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.85	2.75	4.04	11.3	7.78
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.85	2.75	4.04	11.3	34.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	22.2	46.2	49.9	25.6	15.3
Total Liabilities & Shareholders' Equity	26.1	49	53.9	36.9	50.2
Total Common Shares Outstanding